Top Banner
Implantation window. New insights. Jose Miravet-Valenciano Research associate ERA team, IGENOMIX
40

Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

Dec 12, 2018

Download

Documents

buinhu
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

Implantation window. New insights.

Jose Miravet-Valenciano

Research associate ERA team, IGENOMIX

Page 2: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

Synchrony

Page 3: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

Synchrony

Page 4: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

4

WOI

PROLIFERATIVE

EARLY SECRETORYLATE SECRETORYMID

SECRETORY

OVULATION

DAY 0/28 (MENSTRUATION)

DAY 14

IMPLANTATION

SECRETORY FUNCTIONSCELLULAR PROLIFERATIONEXTRACELLULAR MATRIX REMODELATIONANGIOGENESIS AND VASCULOGENESISDNA SYNTHESISADHESION ION CHANNELS

METABOLISMTRANSPORTPROLIFERATIONINHIBITIONMITOSISINHIBITION

METABOLISMGLAND. SECRETIONCELL DIFFERENTIATIONCELL COMMUNICATIONIMMUNE RESPONSERESPONSE TO STREERESPONSE TO WOUNDINGADHESIONPROTEOLYSIS REGULATION

EXTRA CELLULAR MATRIX DEGRADATIONINFLAMATORY RESPONSEAPOPTOSIS

LH peak

PROGESTERONE

PRYMARYFOLLICLE

SECONDARY FOLLICLE VESICULAR

FOLLICLE

CORPUS

LUTEUM

DAY 19DAY 21

Why a good quality embryo does not implant?

Page 5: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

Why a good quality embryo does not implant?

Progesterone

Epithelial

PR

P P+1 P+2 P+3 P+4 P+5 P+6 P+7 P+8 P+9

Page 6: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

Reproductive Medicine. The present

✓ More than 7 million babies have been born worldwide.

✓ 2 – 6% live births in Europe by ART.

(Mansour et al, Hum Reprod. 2014)

✓ 48 million infertile couples in 2010 worldwide.

(Mascarenhas et al, PLoS Med. 2012)

✓ 1,5 million IVF cycles/year worldwide.

Page 7: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

Reproductive Medicine. Our Mission

More and better oocytes?

ONE HEALTHY BABY AT A TIME

Page 8: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

The cross-talk

8

Mechanisms of implantation:

Strategies for successful pregnancy.

(Cha et al, Nature Medicine, 2012)

Page 9: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

The Puzzle of the Endometrial Factor

Omics

Visuals

UltrasoundKasius et al., 2014

HistologyNoyes al., 1950

Coutifaris et al., 2004

Murray et al., 2007

Endometrial SCGargett et al., 2009

Cervello et al., 2010, 2011, 2012

Santamaría et al., 2016

SecretomicsVan der Gaast et al., 2002, 2009

Vilella et al., 2013

TranscriptomicsRiesewijk et al., 2003

Simon et al., 2005

Diaz-Gimeno et al., 2011, 2013

Aghajanova et al., 2012

Microbes

MicrobiotaFranasiak et al., 2015

Moreno et al., 2016

DopplerKupesick et al., 2001

Omics

ESC

HysteroscopyRambouts et al., 2016

ImmunohistochemistryLessey et al., 1995

Kliman et al., 2006

Page 10: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

Endometrial Receptivity Array (ERA)

Page 11: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

Endometrial Receptivity Analysis (ERA)

ERA analyzes the expression of 238 genes in order to determine thepersonalized window of implantation for each patient.

Patented in 2009: PCT/ES 2009/000386

LDT with CLIA

238 genes

Bioinformatic analysis of data

Classification and prediction from gene expression

Page 12: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

Receptive

Predictor Classifies the Molecular ReceptivityStatus of the Endometrium

Post-ReceptivePre-Receptive

Page 13: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

DAY OF THE CYCLE

ENDOMETRIAL BIOPSY

PROGESTERONE (vaginal micronized400 mg/12 hours or similar) ULTRASOUND

>6.5 mm, triple layer< 1 ng/ml endogenous P

P+0 P+5 (120 ± 3h)

ESTRADIOL (Estradiol valerate6 mg/day or similar )

1 2 3 4 5 6 7 8 10 11 12 13 149

MENSTRUATION

Endometrial biopsy in a hormonal replacement cycle (HRT)

Page 14: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

DAY OF THE CYCLE

ENDOMETRIAL BIOPSY

hCG+2

1 2

hCG ADMINISTRATION (hCG + 0)

FOLLICLE > 18 mm

19 20 211817161514

PROGESTERONE (vaginal micronized200 mg/12 hours or similar)

MENSTRUATION

hCG+7

hCG ADMINISTRATION (5000 IU)

Endometrial biopsy in a natural cycle

Page 15: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

Retraining the ERA Algorithms

RECEPTIVE

LATE-RECEPTIVE

EARLY-RECEPTIVE

POST-RECEPTIVE

PRE-RECEPTIVE

PROLIFERATIVE

Page 16: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

Personalized embryo transfer (pET) as a treatment for RIF of endometrial origin

P+5P+3 P+7

LH+7LH+5 LH+9

ETpET

Page 17: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

Scientific evidence

Fertil Steril. 2011 Fertil Steril. 2013

Fertil Steril. 2014

Fertil Steril. 2013 Hum Reprod. 2014

Hum Reprod. 2014 Hum Reprod. 2014

Page 18: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

20,000 PATIENTS

71.4%

Receptive

28.6%

Non-receptive

12.6% Post-

receptive

2.4%

Proliferative

85.0% Pre-

receptive

54 Countries

>600 Clinics

Clinical data

Page 19: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

Study Design

Prospective, Randomized, Multicenter, International,

Open label, Controlled trial

(ClinicalTrials.gov Identifier: NCT01954758)

Initial estimated number size: 546

✓ Patients undergoing IVF/ICSI with their own oocytes

✓ Age ≤ 37 years

✓ BMI: 18.5-30

✓ Normal ovarian reserve (AFC > 8; FSH < 8)

✓ Blastocyst transfer (day 5/6)

✓ PGS was not an inclusion criteria

✓ Pathology affecting the endometrial cavity must be previously

operated

Inclusion criteria

Page 20: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

Day 5/6

DET pETFET

ERATransfer

Cryopreservedembryos

Thawedembryos

HRT

Study Design

Page 21: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

The ERA-RCT Consorcium

Stanford University, USA

IECH Monterrey, Mexico IVI Panama

Centro Reproduçao Nilo

Frantz, Brazil

IVI, Spain (11 sites)

UZ Brussels, University Fertility Center, Belgium

Bahceci Health Group, Turkey

KKH, Singapore

Genesis IVF, Serbia

Oak Clinic, Japan

Instituto Vida Matamoros, Mexico

ReproTec, Colombia

ProcreaTec, Spain

Centro de Infertilidade e Medicina Fetal

do Norte Fluminense, Brazil

Embriofert, BrazilHuntington Medicina Reprodutiva, Brazil

Centro Reproduçao G Mario Covas, Brazil

Sbalagrm Sofia, Bulgary

Active Sites with EC/IRB approval (28)

Recruiting Sites at the Interim (12)

Page 22: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

Reproductive Outcome

* p value <0.05 by Chi-Square test

FET DET pET

Pregnancy rate/ET (%) 61.7 (37/60) 60.8 (45/74) 85.7* (42/49) 0.003

Implantation rate (%) 35.3 (36/102) 41.4 (53/128) 47.8 (43/90) 0.21

Biochemical pregnancies (%) 21.6 (8/37) 6.7 (3/45) 11.9 (5/42) 0.13

Ectopic pregnancies (%) 2.7 (1/37) 0 (0/45) 2.4 (1/42) 0.55

Clinical miscarriages (%) 5.4 (2/37) 20.0 (9/45) 21.4 (9/42) 0.10

Ongoing pregnancy/ET (%) 43.3 (26/60) 44.6 (33/74) 55.1 (27/49) 0.24

Twins (%) 28.6 (8/28) 26.2 (11/42) 19.4 (7/36) 0.66

Singleton (%) 71.4 (20/28) 73.8 (31/42) 80.6 (29/36) 0.66

Page 23: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

The Human Microbiome

• Humans have 10x > bacteria

than cells

• A person of 70 kg weight has

1 Kg of bacteria cohabitants

• Our body contains bacteria,

particularly abundant in the

skin and digestive tract

• Between 20 and 60% of these

bacteria (depending on

location) cannot be cultured

Page 24: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

The Questions

✓ Is there a specific endometrial microbiome?

And if so

✓Could the endometrial microbiome play a role in

endometrial receptivity and pregnancy outcomes?

Page 25: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

✓ Molecular assessment of endometrial microbiota by NGS

ENDOMETRIAL/VAGINAL

ASPIRATION

gDNA

PURIFICATION

16S rRNAgene

BARCODED BACTERIAL 16S rRNA PCR

SEQUENCING DATA ANALYSIS & TAXONOMICAL ASSIGNMENT

Methods

Page 26: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

The evidence

Page 27: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

Study 1

Endometrial and vaginal microbiota differ in some asymptomatic subjects

Subjects: n=13Paired samples Endometrium-Vagina: n=26Total samples analyzed: n=52

Page 28: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

Pre-receptive (LH+2)Receptive (LH+7)E: Endometrial fluidV: Vaginal aspirate

Endometrial vs vaginal microbiota in fertile subjects

Moreno et al., 2016. Am J Obstet Gynecol. 215:684-703

Page 29: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

The uterine cavity is not sterile.

Endometrial and Vaginal Microbiomes

are different in asymptomatic women.

Conclusion Study 1

Page 30: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

Study 2

Regulation of endometrial microbiota during the acquisition of endometrial receptivity

Subjects: n= 22Paired samples LH+2 - LH+7: n=22Total samples analyzed: n=44

Page 31: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

Subjects 1 to 22Pre-receptive (LH2)Receptive (LH7)

High percentage of LactobacillusorLactobacillus-dominated Microbiota

Moreno et al., 2016. Am J Obstet Gynecol. 215:684-703

Endometrial microbiota profile of asymptomatic womenduring the acquisition of endometrial receptivity

Page 32: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

Endometrial Microbiome is not

regulated by hormones during the

acquisition of endometrial receptivity.

Conclusion Study 2

Page 33: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

Study 3

Functional impact of the endometrial microbiota composition on reproductive outcome in patients undergoing IVF

Patients analyzed: n=35Total samples analyzed: n=41

Page 34: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

BMI: body mass index; LDM: Lactobacillus-dominated microbiota; NLDM: non-Lactobacillus-dominated microbiota; *Chi Square (χ² test) and Student’s t-test were performed; *p-value<0.05; §: Voluntary termination of pregnancy.

Low abundance of Lactobacillus in endometrium isassociated with poor reproductive IVF outcomes

Moreno et al., 2016. Am J Obstet Gynecol. 215:684-703

Page 35: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

1.00

0.00

0.75

0.50

0.25

Live birth Non-PregnantMiscarriage

Low abundance of Lactobacillus in endometrium isassociated with poor reproductive IVF outcomes

Moreno et al., 2016. Am J Obstet Gynecol. 215:684-703

Page 36: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

Conclusion Study 3

Endometrial Microbiome affects

embryonic implantation

and ongoing pregnancy.

Page 37: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

Final conclusions

✓ Variability is the law of life, so receptivity depends on the patient.

✓ The transcriptomic signature of endometrial receptivity reveals that the

endometrial factor is responsible for 25% of cases of patients with recurrent

implantation failure.

✓ After correcting the window of implantation, personalized embryo transfer

normalizes clinical results.

✓ The microbiological level should be considered to perform an endometrial receptivity assessment.

Page 38: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

LET’S GO PERSONAL“Insanity: doing the same thing over

and over again and expecting

different results”

“Insanity: doing the same thing over

and over again and expecting

different results”

Final conclusions

Page 39: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.

Our Team

SPAIN

Scientists

AL-ASMAR, NASSER

ALONSO VALERO, ROBERTO

BLESA JARQUE, DAVID

BOVER CATALA, ANA

CAMPOS GALINDO, INMACULADA

CERVERO SANZ, ANA CRISTINA

CLEMENTE CISCAR, MONICA

DIEZ JUAN, ANTONIO

GARCIA HERRERO, SANDRA

GIL SANCHIS, CLAUDIA

GOMEZ DE LA CRUZ, CARLOS ALFONSO

GOMEZ SANCHEZ, EVA MARIA

HERVAS LORENTE, ARANTXA

JIMENEZ ALMAZAN, JORGE

LOPEZ IGLESIAS, PILAR

MARTIN RODRIGUEZ, JULIO CESAR

MARTINEZ CONEJERO, JOSE ANTONIO

MARIN LOPEZ DE CARVAJAL, LUCIA

MARIN VALLEJO, CARLOS

MATEU BRULL, EMILIA

MILAN SANCHEZ, MIGUEL

MIR PARDO, PERE

MIRAVET VALENCIANO, JOSE ALBERTO

MORENO GIMENO, INMACULADA

NAVARRO GAYA, ROSER

PEINADO CERVERA, MARIA VANESSA

POO LLANILLO, MARIA EUGENIA

RINCON BERTOLIN, ALEJANDRO

RODRIGO VIVO, LORENA

RODRIGUEZ IGLESIAS, BEATRIZ

RUBIO LLUESA, CARMEN

RUIZ ALONSO, MARIA

SANCHEZ PIRIS, MARIA ISABEL

SANTAMARIA COSTA, JAVIER

SANZ SALVADOR, LUCIA

SIMON VALLES, CARLOS

VALBUENA PERILLA, DIANA

VERA RODRIGUEZ, MARIA

Collaborators:

SPAIN

Technicians

AGUILA CLARES, BEGOÑA

AYALA ALVAREZ, GUSTAVO LEONARDO

BERMELL JUNCOS, SOLEDAD

BOSCH IBAÑEZ, ALVARO

BURGOS LUJAN, INES

CENTELLES PASTOR, VICENTE

COLOMA MARCO, MARIA DOLORES

ESCOBEDO LUCEA, MILAGROS

ESCORCIA MORA, PATRICIA

FERRO BARBERO, AZARINA

GALVEZ VIEDMA, MARTA

GARCIA BAYARRI, VANESSA

GARCIA MORENO, MIRIAM

GOMEZ LOPEZ, MARIA

HERRERO BAENA, MARIA

IÑIGUEZ QUILES, LAURA

MARTINEZ BENITO, TANTRA

MARTINEZ ESCRIBANO, SEBASTIAN

MARTINEZ FERNANDEZ, MARIA

ASUNCION

MARTINEZ MERINO, LUCIA

MATEOS GREGORIO, PABLO

MOLES SELMA, SARA

MORATA GARCIA, MARIA JESUS

NIETO ALFANI, JESSICA

PERIS PARDO, LAURA

POZO CRUZ, ANA MARIA

SANCHEZ GONZALEZ, ESTELA

USA & CANADA

Scientists

AKINWOLE, ADEDOYIN

CINNIOGLU, CENGIZ

DARVIN, TRISTAN

HARTON, GARY

JAKUBOWSKA MILENA

KAYALI, REFIK

MAE HOOVER, LARISSA

PHILLIPS, KIMBER

SNEIDER, ALYSSA

STANKEWICZ, TIFFANY

YEH, CHRISTINE

Technicians

ALVAREZ, INALVIS

BAUTISTA, ABELARD

BOJI NESCU, ANCA

DUENAS, FRANCISCO

CUI, KATHY

GRIFFIN, MARISA

HAGHI, GHAZAL

LAYNE, NICOLE

LOANIDIS, ALEXANDROS

NGUYEN, VI

PENA, DAYTERNA

PHAM, QUON

SANTI, ANNAI

SEN, GURKAN

SHAIBI, DEREK

TUYEN, KENNY

BRASIL

Scientists

COPRERSKI, BRUNO

ESTEVES MORAES, CAMILA

RIBOLDI, MARCIA

UEHARA DE SOUZA, MARIANE

Technicians

DE GODOI IGLESIAS LIMA, GABRIELLE

SANTANA, LEILA

DUBAI

Scientists

CHOPRA, RUPALI

Technicians

ALNIMS, HAYA

ROY CHOWDGHURY, SHEWETA

SHARMA, SHEWETA

WARRIER EDAKUNNY, SHRUTI

MEXICO

Scientists

BALLESCA ESTRADA, ADRIANA

GARCIA PASCUAL, CARMEN MARÍA

Technicians

CRISTINA COYOTECATL

INDIA

Scientists

KHAJURIA, RAJNI

SINGH BUTTAR, BRINDERJIT

Technicians

UPADHYAY, DIVYESH

Page 40: Jose Miravet-Valenciano Research associate ERA team, …rahr.ru/d_pech_mat_konf/13 Presentation RAHR.pdf · Jose Miravet-Valenciano Research associate ERA team, IGENOMIX. Synchrony.